GABA
Also called gamma-aminobutyric acid, 4-aminobutanoic acid. Amino acid and inhibitory neurotransmitter (natural or fermentation-produced isolate).
Bottom line
GABA (gamma-aminobutyric acid), the brain's main inhibitory neurotransmitter, is also sold as an oral supplement [1][2]. A 2020 systematic review of 14 trials, led by a Unilever employee, found limited evidence for stress and very limited evidence for sleep; in 11 trials an author worked for a company [1]. How much oral GABA reaches the brain is unclear [2][3].
- A 2020 systematic review of 14 placebo-controlled trials, whose first author was employed by Unilever, found limited evidence that oral GABA affects stress and very limited evidence for sleep [1].
- All four sleep-latency trials we found were run or funded by GABA suppliers, and those with a stated length lasted 1 to 4 weeks [4][5][6][7][1].
- Two double-blind attention studies using 800 mg disagreed, and a third found worse task switching than placebo [14][15][16].
- A USP safety review found no serious adverse events at intakes up to 18 g a day for 4 days, and noted transient, moderate drops in blood pressure of under 10% [3].
- Health Canada lists GABA for temporary relaxation at 50-3,000 milligrams a day and requires an alcohol warning at 300 mg or more a day [28].
Evidence by outcome
| Outcome | Grade | Basis | Modifiers | Rationale |
|---|---|---|---|---|
| Attention | C Limited, no effect found | Small acute placebo-controlled studies with conflicting results | Short-term only | Why C grade for Attention: explainedApproved of the Attention grade |
| Perceived stress | C Limited, no effect found | Small single-dose studies measuring mostly physiological markers; self-reported stress did not change consistently | Industry-fundedShort-term only | Why C grade for Perceived stress: explainedApproved of the Perceived stress grade |
| Sleep latency | C Limited, no effect found | Small trials, mostly in poor sleepers or adults with insomnia symptoms; mixed against placebo; not B under the rubric (no double-blind RCT of 100 or more, and the second RCT was not significant against placebo) | Industry-fundedShort-term only | Why C grade for Sleep latency: explainedApproved of the Sleep latency grade |
| Sleep quality | C Limited, no effect found | Mixed small RCTs; not N under the rubric (no adequately sized null trial on a primary sleep-quality outcome) | Short-term only | Why C grade for Sleep quality: explainedApproved of the Sleep quality grade |
| Blood pressure | C Limited | Two small RCTs in people with high-normal to mildly raised blood pressure, using GABA in a fermented milk or a Chlorella supplement | Short-term only | Why C grade for Blood pressure: explainedApproved of the Blood pressure grade |
Grades describe evidence for each outcome, not a recommendation. Open a grade for its rationale and dated grade history. How we grade
Our grades are proposals per outcome; the evidence grading method explains what each grade requires, and the evidence matrix compares GABA with other compounds. Two features of this evidence run through every section. A 2020 systematic review of placebo-controlled trials found that at least one author of 11 included studies was employed by an industrial company when the study was published [1]. A 2015 review likewise noted that most evidence for a calming effect came from researchers with a potential conflict of interest [2].
As of November 11, 2026 we found no meta-analysis of oral GABA trials for sleep, stress or blood pressure (PubMed search, November 11, 2026). Findings for sleep and relaxation are relevant to our sleep and mood and stress goal pages.
Does GABA help you fall asleep faster?
Results for sleep latency, the time taken to fall asleep, are limited and mixed [1][6][7]. The 2020 systematic review, which included 14 placebo-controlled studies, found very limited evidence for sleep benefits of oral GABA [1].
Two crossover studies in poor sleepers were run by researchers employed by Pharma Foods International, a GABA manufacturer [4][5]. In the first, a single-blind crossover in 10 poor sleepers given 100 mg, GABA shortened sleep latency and increased non-REM sleep time compared with placebo [4][1]. In the second, 16 poor sleepers given 100 mg had sleep latency 5.3 minutes shorter with GABA, but the abstract gives no placebo comparison [5][1].
Two double-blind trials were funded by the ingredient supplier Natural Way Co., which also supplied the GABA [6][7]. In 40 adults with insomnia symptoms, a clinical population, 300 mg a day for 4 weeks reduced sleep latency on overnight polysomnography from 13.4 to 5.7 minutes in the GABA group [6]. This was the only measure with a significant group-by-time difference from placebo, but the placebo group had just 10 people and the groups differed at the start [6]. In a follow-up trial of 54 adults with insomnia given 75 mg a day, sleep latency fell from 9.0 to 4.8 minutes, but the change was not significant relative to placebo [7]. Results in clinical groups may not apply to healthy adults.
Does GABA improve sleep quality?
Evidence is mixed: questionnaire scores improved on placebo too in one trial and did not change in another [7][9]. In a double-blind trial of 30 sedentary women with overweight or obesity who were taking part in an exercise program, 200 mg once daily for 90 days was followed by better habitual sleep efficiency, shown by lower Pittsburgh Sleep Quality Index scores, in the GABA group; the abstract gives no comparison with placebo [8].
In the supplier-funded 75 mg insomnia trial, sleep questionnaire scores fell in both the GABA and placebo groups [7], and in the 300 mg trial the group-by-time difference was significant only for sleep latency [6]. In 52 adults with prediabetes, a clinical population, 500 mg three times daily for 95 days did not change self-reported sleep quality after correction for multiple testing, a secondary outcome of that trial [9].
Does GABA reduce stress?
Studies mostly measured the body's stress markers rather than how stressed people felt, and the 2020 review rated the evidence for stress as limited [1]. Most were single-dose experiments, and several were run by researchers employed by Pharma Foods International, Ezaki Glico or Coca-Cola (Japan) [10][11][12][13].
- In two small experiments by researchers employed by Pharma Foods International, 100 mg of GABA increased alpha brain waves and decreased beta waves compared with water or L-theanine in 13 people. In 8 people with a fear of heights crossing a suspended bridge, GABA (dose not stated) kept salivary immunoglobulin A higher than placebo [10][1].
- In a randomized, single-blind crossover in 63 adults, with four of its nine authors from Pharma Foods International, 100 mg reduced the fall in EEG activity during stressful mental tasks compared with placebo [11]. The authors reported that mood questionnaire scores matched the EEG result [11], but the 2020 review found that participants did not report feeling more relaxed or less tense [1].
- In studies run by researchers employed by Ezaki Glico, chocolate enriched with 28 mg of GABA was followed by a faster recovery of heart rate variability after an arithmetic task [12].
- In a trial run by researchers employed by Coca-Cola (Japan) and Pharma Foods International, with 30 adults of whom 9 had chronic fatigue, a drink with 50 mg of GABA lowered ratings of psychological fatigue compared with a drink without GABA [13].
Health Canada lists two of these studies among the references it consulted for the relaxation use it allows on licensed products [28].
Does GABA affect attention?
Three single-dose studies in healthy young adults disagree [14][15][16]. A 2018 double-blind experiment found that GABA, at 800 mg according to a later paper, left spatial attention unchanged and improved some measures of temporal attention, with significantly fewer order errors but no significant change in the attentional blink [14][15]. Two of its authors also wrote the retracted 2015 trial described below [14][17].
A 2023 double-blind crossover in 32 young adults, with no outside funding, tested 800 mg and found no effect on temporal attention, visual search accuracy or working memory precision, while visual search took longer than with placebo [15]. In a third trial with 12 people per group, 800 mg of GABA worsened task switching, a measure of cognitive flexibility, compared with placebo [16].
A 2015 trial reporting that GABA improved action selection was retracted by the journal in 2022, so it is not used here [17].
Does GABA lower blood pressure?
Two 12-week trials, one of a GABA-containing fermented milk and one of a GABA-rich Chlorella supplement, found lower systolic blood pressure, the top number, in people whose blood pressure was already high-normal or raised [18][19]. In a single-blind trial of 39 adults with mild hypertension, a clinical population, a fermented milk containing GABA lowered systolic blood pressure by a mean of 17.4 mmHg from baseline, and systolic pressure differed significantly from the placebo group [18]. In a double-blind trial of 80 adults with high-normal blood pressure or borderline hypertension, GABA-rich Chlorella providing 20 mg of GABA twice daily lowered systolic blood pressure compared with placebo [19].
In the 95-day prediabetes trial, blood pressure was a secondary outcome and showed no significant effect after correction for multiple testing [9]. The USP review describes the drop seen in some studies as transient and moderate, less than a 10% change [3]. Results in people with raised blood pressure may not apply to healthy adults.
What the evidence does not show
The attention results conflict, and the one trial that measured working memory found no effect [15]. Separately, in 2009 EFSA found that none of the references provided for a cognitive function claim directly addressed the relationship between dietary GABA and cognitive function [29]. GABA raised growth hormone at rest compared with placebo in 11 resistance-trained men given 3 g [22], but the authors said the extent to which this contributes to muscle growth is unknown [22]. A 12-week trial in 21 healthy men doing resistance training found a larger gain in fat-free mass when 100 mg of GABA was added to whey protein, and it was run by researchers employed by Pharma Foods International, which provided the GABA [23]. Other compounds studied for sleep have their own pages, including melatonin, glycine, magnesium and L-theanine.
Doses used in studies
Ranges researchers used, not dosing advice. Bars share one scale. Read our disclaimer.
2-3 g single dose; 2 g three times daily for 7 days
Timing and form
Oral GABA is absorbed quickly [20][4]. In 12 healthy volunteers given 2 g, GABA peaked in the blood within 0.5 to 1 hour and had a half-life, the time for the blood level to fall by half, of 5 hours [20]. It did not build up over 7 days of three daily doses [20]. A sleep study run by researchers employed by Pharma Foods International found blood GABA was highest 30 minutes after a dose [4].
In one study of 11 healthy men, GABA from pureed tomatoes had similar bioavailability to GABA dissolved in water [21]. In two stress studies, effects were measured 30 to 60 minutes after a single dose [10][11].
What it is
GABA, short for gamma-aminobutyric acid, is an amino acid and the main inhibitory neurotransmitter in the mammalian brain [1]. Health Canada lists it under the proper name 4-aminobutanoic acid, with CAS registry number 56-12-2 [27]. This page covers GABA taken by mouth, not the brain's own GABA system.
GABA also occurs in food. A USP review reports high GABA levels in brown rice germ, sprouted cereals and spinach, and high amounts in lactic acid-fermented foods such as cured meats and cheeses [3]. Supplement GABA can be made by fermentation: Health Canada's ingredient record names bacteria such as Lentilactobacillus hilgardii as source organisms for biosynthesis [27].
In the US, USP describes GABA as a dietary ingredient sold in numerous dietary supplements [3], and Health Canada classifies it as a natural health product under the isolate category of its regulations [27].
How it works (mechanism, not effect): whether oral GABA reaches the brain is an open question. A 2015 review said it has long been thought that GABA cannot cross the blood-brain barrier, but that the studies on this are contradictory and use widely different methods [2]. The 2021 USP review concluded that very low amounts of GABA cross from the blood into the brain, whether it is given by mouth or by vein [3]. The 2015 review called the mechanism far from clear [2].
Safety and interactions
Safety flag. A USP safety review found no serious adverse events at intakes up to 18 g a day for 4 days, or 120 mg a day for 12 weeks [3]. Reported side effects included abdominal discomfort, headache, drowsiness and a transient burning sensation in the throat, classified as mild to moderate [3]. No studies were available on GABA in pregnancy or breastfeeding, and USP advises caution in pregnant and lactating women [3]. Health Canada requires products providing 300 mg or more a day to advise avoiding alcohol and asking a health care practitioner before use beyond 4 weeks [28].
Who sources say should be careful.
- Pregnant or breastfeeding women. USP found no studies of GABA in pregnancy or lactation and advises caution, because GABA can affect hormones, including growth hormone and prolactin [3]. Health Canada's cognitive function monograph includes a statement to ask a health care practitioner before use if pregnant or breastfeeding [28].
- People taking medicines for high blood pressure or epilepsy, for whom USP describes a possible interaction (see interactions) [3].
- People who drink alcohol while using 300 mg or more a day, which Health Canada says to avoid [28].
- Anyone planning use beyond 4 weeks at 300 mg or more a day. Health Canada requires labels to advise asking a health care practitioner first [28].
In the trials reviewed by USP, no serious adverse events were linked to GABA at intakes up to 18 g a day for 4 days, or 120 mg a day for 12 weeks [3]. Reported side effects included abdominal discomfort, headache, drowsiness and a transient burning sensation in the throat, classified as mild to moderate [3]. In three short studies giving 5 to 18 g, a few participants felt a slight burning sensation in the throat right after taking GABA, sometimes with brief shortness of breath [3].
In a pharmacokinetic study in 12 healthy volunteers, 2 g three times daily for 7 days brought more minor adverse events than placebo or a single dose, mostly dizziness and sore throat, with no serious events [20]. In the 300 mg insomnia trial funded by the supplier Natural Way, 4 of 40 people (10%) had adverse events, including mild gastrointestinal discomfort and headache, and two reported drowsiness [6]. The 75 mg trial, funded by the same supplier, reported none [7]. A one-year trial in 97 children with type 1 diabetes, a clinical population, concluded that oral GABA was tolerable at about 35 mg/kg a day in two doses; it was co-funded by Diamyd Medical and Janssen, and NOW Foods supplied the GABA [24].
USP found no case reports of adverse events with GABA in the literature [3]. In FDA's adverse event database (CAERS), 97% of reports for products containing GABA involved multi-ingredient products, and causality could not be assigned [3]. Health Canada's adverse reaction database held one serious report, in a man taking 500 mg a day for 247 days, but he was also using other suspect products, so USP called the role of GABA uncertain [3]. Chronic administration to rats and dogs at doses up to 1 g/kg a day showed no signs of toxicity [3].
As of November 11, 2026 we found no market testing of GABA supplement contents against their labels (PubMed search, November 11, 2026).
Interactions sources report
As of November 11, 2026 we found no human study of interactions between oral GABA and any medicine (PubMed search, November 11, 2026). The USP review cites one clinical study in which more GABA reached the brain when taken with phosphatidylserine, and on that basis USP says GABA may interact with medicines used for epilepsy [3]. Because some studies found GABA lowered blood pressure, USP also says it is conceivable that GABA may interact with blood pressure medicines, such as propranolol or metoprolol, and increase the risk of hypotension, meaning blood pressure that is too low [3]. Health Canada requires products providing 300 mg or more of GABA a day to advise avoiding alcohol [28].
These sources describe what has been reported, not what is right for any individual. If you take any of these medicines, talk to your doctor or pharmacist before combining them with GABA.
Regulatory status
| Market | Status | Notes |
|---|---|---|
| US | No FDA statement specific to GABA as a dietary supplement found as of November 11, 2026. Under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed. A 2015 GRAS notice for GABA in foods (GRN 595) was withdrawn by the notifier, and FDA ceased to evaluate it. | |
| UK | Not verified as of November 11, 2026. We checked GOV.UK, the Food Standards Agency site and the GB regulated products register and found no page or authorization for GABA. | |
| Canada | Classified as a natural health product (isolate). Listed in Health Canada's Cognitive Function Products monograph (dated January 30, 2026) for temporary relaxation at 50-3,000 milligrams per day, no more than 750 milligrams per single dose, with required cautions. | |
| Australia | Not verified as of November 11, 2026. No entry for GABA in the Permissible Ingredients Determination (No. 3) 2026 or the October 2026 Poisons Standard; a 2021 USP review (not a regulator source) reported that GABA was then not on the ARTG. The ARTG was not searched. | |
| EU | Not verified as of November 11, 2026. No entry for GABA in the EU Novel Food status Catalogue. In 2009 EFSA concluded that a cause and effect relationship had not been established between dietary intake of GABA and cognitive function. |
FAQ
Does a GABA supplement help with sleep?
A 2020 systematic review, whose first author was employed by Unilever, found very limited evidence for sleep benefits of oral GABA [1]. Small supplier-run or supplier-funded trials reported shorter time to fall asleep [4][6], but in a 54-person trial using 75 mg the change was not significant compared with placebo [7].
Does oral GABA cross the blood-brain barrier?
This is unresolved. A 2015 review called the studies contradictory and widely varied in method [2], and the USP review concluded that very low amounts cross from blood into the brain [3]. Any effects might also act through the nerves of the gut, which the 2015 review raised as a possibility [2].
What are the side effects of GABA?
Reported side effects included abdominal discomfort, headache, drowsiness and a short-lived burning sensation in the throat, classified as mild to moderate [3]. In a 7-day study of 2 g three times daily, minor events such as dizziness and sore throat were more common than with placebo [20].
How much GABA did studies use?
Two sleep trials funded by the supplier Natural Way used 75 or 300 mg a day [6][7]. Single-dose stress and attention studies used 25-800 mg; the lowest was in a fatigue study run by researchers employed by Coca-Cola (Japan) and Pharma Foods International [13][1][15]. A pharmacokinetic study used 2 g doses [20]. These are study doses, not advice.
References
- Hepsomali P, Groeger JA, Nishihira J, et al. Effects of Oral Gamma-Aminobutyric Acid (GABA) Administration on Stress and Sleep in Humans: A Systematic Review. Front Neurosci. 2020.
- Boonstra E, de Kleijn R, Colzato LS, et al. Neurotransmitters as food supplements: the effects of GABA on brain and behavior. Front Psychol. 2015.
- Oketch-Rabah HA, Madden EF, Roe AL, et al. United States Pharmacopeia (USP) Safety Review of Gamma-Aminobutyric Acid (GABA). Nutrients. 2021.
- Yamatsu A, Yamashita Y, Pandharipande T, et al. Effect of oral γ-aminobutyric acid (GABA) administration on sleep and its absorption in humans. Food Sci Biotechnol. 2016.
- Yamatsu A, Yamashita Y, Maru I, et al. The Improvement of Sleep by Oral Intake of GABA and Apocynum venetum Leaf Extract. J Nutr Sci Vitaminol (Tokyo). 2015.
- Byun JI, Shin YY, Chung SE, et al. Safety and Efficacy of Gamma-Aminobutyric Acid from Fermented Rice Germ in Patients with Insomnia Symptoms: A Randomized, Double-Blind Trial. J Clin Neurol. 2018.
- Yoon S, Byun JI, Shin WC. Efficacy and Safety of Low-Dose Gamma-Aminobutyric Acid From Unpolished Rice Germ as a Health Functional Food for Promoting Sleep: A Randomized, Double-Blind, Placebo-Controlled Trial. J Clin Neurol. 2022.
- Guimarães AP, Seidel H, Pires LVM, et al. GABA Supplementation, Increased Heart-Rate Variability, Emotional Response, Sleep Efficiency and Reduced Depression in Sedentary Overweight Women Undergoing Physical Exercise: Placebo-Controlled, Randomized Clinical Trial. J Diet Suppl. 2024.
- de Bie TH, Witkamp RF, Balvers MG, et al. Effects of γ-aminobutyric acid supplementation on glucose control in adults with prediabetes: A double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2023.
- Abdou AM, Higashiguchi S, Horie K, et al. Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. Biofactors. 2006.
- Yoto A, Murao S, Motoki M, et al. Oral intake of γ-aminobutyric acid affects mood and activities of central nervous system during stressed condition induced by mental tasks. Amino Acids. 2012.
- Nakamura H, Takishima T, Kometani T, et al. Psychological stress-reducing effect of chocolate enriched with gamma-aminobutyric acid (GABA) in humans: assessment of stress using heart rate variability and salivary chromogranin A. Int J Food Sci Nutr. 2009.
- Kanehira T, Nakamura Y, Nakamura K, et al. Relieving occupational fatigue by consumption of a beverage containing γ-amino butyric acid. J Nutr Sci Vitaminol (Tokyo). 2011.
- Leonte A, Colzato LS, Steenbergen L, et al. Supplementation of gamma-aminobutyric acid (GABA) affects temporal, but not spatial visual attention. Brain Cogn. 2018.
- Tınok AA, Karabay A, Jong J, et al. Effects of gamma-aminobutyric acid on working memory and attention: A randomized, double-blinded, placebo-controlled, crossover trial. J Psychopharmacol. 2023.
- Lim LW, Aquili L. GABA Supplementation Negatively Affects Cognitive Flexibility Independent of Tyrosine. J Clin Med. 2021.
- Steenbergen L, Sellaro R, Stock AK, et al. Retraction Note: γ-Aminobutyric acid (GABA) administration improves action selection processes: a randomised controlled trial. Sci Rep. 2022.
- Inoue K, Shirai T, Ochiai H, et al. Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr. 2003.
- Shimada M, Hasegawa T, Nishimura C, et al. Anti-hypertensive effect of gamma-aminobutyric acid (GABA)-rich Chlorella on high-normal blood pressure and borderline hypertension in placebo-controlled double blind study. Clin Exp Hypertens. 2009.
- Li J, Zhang Z, Liu X, et al. Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics. Front Pharmacol. 2015.
- de Bie TH, Balvers MGJ, de Vos RCH, et al. The influence of a tomato food matrix on the bioavailability and plasma kinetics of oral gamma-aminobutyric acid (GABA) and its precursor glutamate in healthy men. Food Funct. 2022.
- Powers ME, Yarrow JF, McCoy SC, et al. Growth hormone isoform responses to GABA ingestion at rest and after exercise. Med Sci Sports Exerc. 2008.
- Sakashita M, Nakamura U, Horie N, et al. Oral Supplementation Using Gamma-Aminobutyric Acid and Whey Protein Improves Whole Body Fat-Free Mass in Men After Resistance Training. J Clin Med Res. 2019.
- Martin A, Mick GJ, Choat HM, et al. A randomized trial of oral gamma aminobutyric acid (GABA) or the combination of GABA with glutamic acid decarboxylase (GAD) on pancreatic islet endocrine function in children with newly diagnosed type 1 diabetes. Nat Commun. 2022.
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. Updated August 27, 2026.
- U.S. Food and Drug Administration. Agency Response Letter GRAS Notice No. GRN 000595. Updated February 16, 2018.
- Health Canada, Natural and Non-prescription Health Products Directorate. Natural Health Products Ingredients Database: Chemical Substance - gamma-Aminobutyric acid. Updated February 5, 2026.
- Health Canada, Natural and Non-prescription Health Products Directorate. Natural Health Products Ingredients Database monograph: Cognitive Function Products. Updated January 30, 2026.
- European Food Safety Authority, Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on the substantiation of health claims related to gamma-aminobutyric acid and cognitive function (ID 1768) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2009;7(9):1274. doi:10.2903/j.efsa.2009.1274. Updated October 1, 2009.
- European Commission. Novel Food status Catalogue.
- Food Standards Agency. Authorised Regulated Food and Feed Products for Great Britain (novel food authorisations search: "aminobutyric").
- Australian Government, Department of Health, Disability and Ageing (Federal Register of Legislation). Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026 (F2026L01382). Updated October 13, 2026.
- Australian Government, Department of Health, Disability and Ageing (Federal Register of Legislation). Therapeutic Goods (Poisons Standard - October 2026) Instrument 2026 (F2026L01327). Updated September 30, 2026.